CVRx vs IRIDEX
CVRx reported revenue of $57 million in fiscal 2025, about the same as IRIDEX's $53 million in fiscal 2025. CVRx's revenue grew 10.4% in its latest year, and IRIDEX's grew 8.2%. CVRx had an operating margin of -90.5%, against -4.9% at IRIDEX. Free cash flow was −$41 million at CVRx and −$2 million at IRIDEX. Their fiscal years end in different months (December 31 and January 3), so the periods don't line up exactly.
Side by side
| CVRx | IRIDEX | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Jan 3, 2026 |
| Revenue | $57M | $53M |
| Revenue growth | 10.4% | 8.2% |
| Revenue growth a year, last 5 years | 56.2% | 7.7% |
| Gross margin | 85.3% | 36.5% |
| Operating margin | −90.5% | −4.9% |
| Net margin | −94.1% | −8.4% |
| Free cash flow | −$41M | −$2M |
| Free cash flow margin | −71.9% | −4.3% |
| Return on capital | −294.3% | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 15.4% | 3.0% |
| Last close | $0.53 | $0.47 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $376,741, sold $220,566 | — |
| Piotroski F-score | 3 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CVRxIRIDEX
Operating margin
Percent of revenue
CVRxIRIDEX
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CVRxIRIDEX